Neutrophilic Dermatoses

Published on 05/03/2015 by admin

Filed under Dermatology

Last modified 05/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3339 times

21

Neutrophilic Dermatoses

This group of disorders, in an untreated state, is characterized by infiltrates of neutrophils within the skin. In addition, these dermatoses lack an identifiable infectious etiology, despite the presence of neutrophils (Fig. 21.1). There can be significant overlap in the clinical presentations of the neutrophilic dermatoses; for example, in a patient with acute myelo­genous leukemia, bullous pyoderma gangrenosum may be difficult to distinguish from Sweet’s syndrome. In addition, infiltrates of neutrophils can occur in other organs, particularly the joints, eyes, lungs, and bones. Bone involvement raises the possibility of SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome.

Sweet’s Syndrome (Acute Febrile Neutrophilic Dermatosis)

Acute onset of erythematous edematous papules and plaques that are tender, but not pruritic; if the edema is intense, the lesions may become bullous and, occasionally, they resemble erysipelas; favored sites are the face, neck, upper trunk, and upper extremities (Fig. 21.2).

Less commonly, nodules develop due to neutrophilic panniculitis or pustules form within the plaques; a variant occurs on the dorsal aspect of the hands and is referred to as ‘neutrophilic dermatosis of the dorsal hands’ (Fig. 21.3).

Associated systemic findings include fever, malaise, and arthralgias, and a peripheral leukocytosis is commonly observed (Table 21.1); some patients also develop systemic manifestations, including ocular, pulmonary, and skeletal involvement (Fig. 21.4, Table 21.2).

Most often seen in adults, with a female:male ratio of 4 : 1 (except in the case of malignancy-associated disease); may first appear or flare during pregnancy; idiopathic in up to 50% of patients.

Underlying disorders include: (1) infections – upper respiratory tract (e.g. viral, streptococcal) or gastrointestinal (e.g. yersinosis) > HIV or atypical mycobacteria; (2) hematologic malignancies (10–20% of patients), particularly acute myelogenous leukemia (AML) but also myelodysplasia and myeloproliferative disorders; (3) inflammatory bowel disease; (4) autoimmune connective tissue disease, particularly systemic lupus erythematosus (SLE); (5) drugs – G-CSF, all-trans-retinoic acid > furosemide, minocycline; and (6) carcinomas – genitourinary, breast, colon.

The vesiculobullous form is more often associated with AML, and in malignancy-associated Sweet’s syndrome, the lesions tend to be more widespread, including within the oral cavity.

Histologically, diffuse infiltrates of neutrophils are seen within the dermis and occasionally the subcutaneous fat; leukocytoclastic vasculitis is absent or minimal.

DDx: bullous pyoderma gangrenosum, neutrophilic eccrine hidradenitis, erysipelas, erythema multiforme, causes of pseudocellulitis (see Table 61.2), infectious cellulitis, vasculitis (urticarial, small vessel, septic), halogenoderma, periodic fever syndromes, as well as additional entities in Fig. 21.1.

There are differing opinions regarding whether the development of a nonbullous neutrophilic dermatosis in the setting of LE is a distinct entity or is simply Sweet’s syndrome associated with LE.

Rx: